Back to Research Hub
Embecta Corp.
EMBC
$3.31-0.03 (-0.90%)
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.
StreetsValue research for Embecta Corp. (EMBC)
Members get the full report for Embecta Corp.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.